Cost-effectiveness analysis of population-based BRCA1/2 testing, family-history-based BRCA1/2 testing, and symptom-based screening for breast and ovarian cancer in China

BackgroundThe women’s cancer screening program has been operational for several years in China, primarily utilizing palpation and ultrasound. Given the proven impact of BRCA1/2 mutations on the incidence of breast and ovarian cancer, the cost-effectiveness of incorporating BRCA1/2 mutation testing i...

Full description

Saved in:
Bibliographic Details
Main Authors: Feilong Zhao, Shu Wang, Jianfei Lu, Xiangying Feng, Liwei Ran, Jianjun Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2025.1479966/full
Tags: Add Tag
No Tags, Be the first to tag this record!